Gastroparesis: Naronapride Study

We are evaluating a new medication for people with moderate gastroparesis to see how it works and its safety compared to healthy individuals. This study aims to improve treatment options for those affected by this condition.

Safety phase (I)Gastroenterology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
UZ Leuven
Gastroenterology
Heverlee, Belgium
SocraTec R&D Concepts in Drug Research and Development GmbH
CPU
Erfurt, Germany
Biokinetica S.A.
n.a.
Józefów, Poland
Sponsor: Dr. Falk Pharma GmbH
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.